Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Chinese Neurosurgical Journal is Scopus-indexed (Q2, CiteScore 3.2), WoS ESCI, DOAJ. Published by BioMed Central Ltd.
Checked against the index lists dated .
ISSN 2057-4967Verify ISSN ↗
Publisher: BioMed Central Ltd
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Surgery | 185 / 597 | 69th | Q2 |
| Neurology (clinical) | 226 / 403 | 44th | Q3 |
| Neurology | 123 / 201 | 39th | Q3 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2015–present, best quartile Q2, CiteScore 3.2.
Chinese Neurosurgical Journal is Q2 in Surgery (rank 185 of 597), Q3 in Neurology (clinical) (rank 226 of 403) and Q3 in Neurology (rank 123 of 201), by CiteScore 2025.
Chinese Neurosurgical Journal is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 3.2, which places it in quartile Q2 at the 69th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.559, quartile Q2, with an H-index of 19.
No article processing charge is recorded for it (source: OpenAlex). Confirm on the journal's own website, since some journals charge for extras such as colour figures.
Chinese Neurosurgical Journal is published by BioMed Central Ltd. Its ISSN is 2057-4967.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Chinese Neurosurgical Journal has an h-index of 24 and a 2-year mean of 1.83 citations per paper (OpenAlex). Its Scopus CiteScore is 3.2, quartile Q2. On 2-year citations it ranks #145 of 585 Scopus journals in Surgery.
Chinese Neurosurgical Journal published 33 papers in 2025; its busiest recent year was 2021 with 50. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2023–2026), authors are most often from China (64.8%), United States (7.9%) and United Kingdom (4%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.